Singaporean AI wellness tech startup Bot MD has entered into partnerships with important Indonesian organisations to utilise AI assistant technologies in driving patient and clinician practical experience. 

WHAT It is ABOUT

The startup signed a memorandum of understanding with Siloam Hospitals Group to automate and scale patient-reported outcome measures (PROM) across its hospital chain by powering Siloam’s WhatsApp with the Bot MD Care AI chatbot. 

For the duration of visits, the chatbot automatically notifies sufferers by way of WhatsApp to gather their baseline health-related situation. It automatically reminds them and collects their PROMs pre- and post-surgery and then scores their outcomes. The AI platform can also provide automatic reminders and education data to sufferers. 

Bot MD Care is now readily available to sufferers getting treatment options for heart failure or ischemic heart illness at Siloam Hospitals Lippo Village in Tangerang. There are also plans to progressively roll out the AI service across other hospitals later. Siloam Hospitals will also expand the service to cover other clinical places and integrate it into its EMR method to make it simpler for clinicians to overview patient progress.

Meanwhile, Bot MD also partnered with the Indonesian Healthcare Association (IDI) to embed its AI assistant on the latter’s web page. This integration enables much more than 200,000 medical doctor members of the organisation to immediately search for association data, IDI solutions and national recommendations. 

By way of the IDI Bot, medical doctors can effortlessly seek data on new memberships, apply for an electronic membership card, report problems with membership activation, renew their competency certificate, and submit feedback to IDI. Accessible in each Bahasa Indonesia and English, the IDI Bot has been educated on often asked inquiries from IDI members. 

WHY IT MATTERS

As a single of Indonesia’s biggest private hospital groups with 41 hospitals and 66 clinics, Siloam treats and supplies care for much more than 5 million special sufferers every year. Adopting an AI chatbot will enable scale its information collection across a variety of clinical situations, as properly as benchmark and measure patient outcomes across its hospitals, which eventually informs clinicians in improving their quality of care.

Meanwhile, Bot MD is supporting IDI’s digital transformation journey to boost the excellent and availability of its solutions. The association is keen to expand its partnership with the startup in the future by powering WhatsApp and its other chat platforms with AI to boost access to solutions for its members.

Following constructive outcomes from this partnership, Bot MD now plans to introduce the service to other health-related associations across Southeast Asia. 

THE Bigger TREND

Two years ago, Bot MD raised $five million in a funding round which went to its regional expansion efforts. The firm had locked its sights on Indonesia, the Philippines, Malaysia and India.

For the duration of the pandemic, its AI assistant has been deployed across public hospitals in Singapore to aid with remote important indicators monitoring and collection.